Related Experiment Video
Updated: Oct 24, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Comparison of Non-invasive Diagnostic Methods for Helicobacter Pylori Infection Before and After Treatment
Seyedeh Azra Shamsdin1, Hossein Faramarzi2, Hajar Khazraei3
1Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Introduction:
Helicobacter pylori (H. pylori) infection is a major contributor to peptic ulcer disease and other gastrointestinal disorders. The present study aimed to investigate the effect of treatment on diagnostic outcomes by comparing two non-invasive methods-the stool antigen test and the serological IgG antibody test, before and after therapy. This approach was designed to evaluate not only the diagnostic efficacy of these tools but also the changes in antibody responses following eradication treatment.
Methods:
This observational study was conducted from 2021 to 2022 at Shahid Motahari Clinic, affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. A total of 108 patients with dyspepsia and confirmed H. pylori infection were enrolled. Diagnostic tests included stool antigen, anti-H. pylori IgG serology, and the urease breath test (UBT). Patients received standard triple therapy, with stool antigen and IgG levels measured before and one month after treatment to assess diagnostic accuracy and treatment outcomes.
Results:
Among 108 patients, 74% had peptic ulcer disease. The UBT showed the highest diagnostic accuracy (100% sensitivity, 94.6% specificity). Anti-H. pylori IgG serology had high sensitivity (100%) but lower specificity (66.2%). The stool antigen test demonstrated moderate accuracy. After treatment, stool antigen levels significantly decreased (from 4.2±0.64 to 2.9±0.75, P=0.03), and IgG titers declined significantly (from 54.26±3.33 to 46.51±3.22, P<0.0001).
Conclusion:
Our findings underscore UBT as the most accurate method and highlight the value of stool antigen testing for follow-up. Monitoring IgG titer changes may support treatment assessment when used alongside other tools, though its low specificity limits stand-alone use.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications